SOPHiA GENETICS™ is excited to be a part of the 31st International Precision Med Tri-Con Conference, held in person in San Diego, California from March 26th – 28th.
Stop by booth #124 for a chance to meet our experts, get a sneak peak into the capabilities of the SOPHiA DDM™ Platform and to discover the breadth of our liquid biopsy capabilities.
JLUNCHEON PRESENTATION
Unlocking access to MSK-ACCESS®: A decentralized approach to innovative liquid biopsy technology
Thursday, March 27 | 1:00 -1:30 pm | Liquid Biopsy Track
SOPHiA GENETICS is collaborating with MSK to decentralize MSK-ACCESS® for liquid biopsy. By combining MSK’s clinical expertise in cancer genomics and the predictive algorithms of the SOPHiA DDMTM Platform, we aim to expand access to precision cancer analysis capabilities worldwide. Join our expert speakers to gain insights into the clinical utility of liquid biopsy at MSK and explore the analytical performance data of MSK-ACCESS® powered with SOPHiA DDMTM – a decentralized application.
Speakers:
Rose Brannon, PhD – Director of Clinical Bioinformatics, Memorial Sloan Kettering Cancer Center (MSK)
Chloe Ryder, PhD – Product Manager for Liquid Biopsy, SOPHiA GENETICS
